Epidemiological, clinical, and molecular characteristics of coxsackievirus A2 infections during a herpangina outbreak in children on an Island in Eastern China in 2024: a surveillance-based study

2024年中国东部某岛屿儿童疱疹性咽峡炎暴发期间柯萨奇病毒A2感染的流行病学、临床和分子特征:一项基于监测的研究

阅读:3

Abstract

BACKGROUND: Herpangina is an acute pediatric illness caused by enteroviruses, yet the predominant circulating serotype in mainland China has not been well characterized. In this study, Coxsackievirus A2 (CV-A2) emerged as the dominant serotype among herpangina cases in Yuhuan City, Zhejiang Province. These findings underscore the importance of further research into the epidemiological distribution and molecular features of CV-A2 in this region. METHODS: A total of 133 child herpangina cases were included during May and June 2024. Enteroviruses were detected using RT-PCR, followed by serotyping and sequencing. Phylogenetic and recombination analyses were performed to assess genetic diversity and evolutionary relationships. RESULTS: Among the 133 cases (median age: 3 years), 88.7% tested positive for enteroviruses. CV-A2 was predominant (78.0%), followed by CV-A4, CV-A5, CV-A10, CV-A16, and CV-B4. Fever (95.5%) and oral vesicles (98.5%) were the most common symptoms. Compared to other serotypes, CV-A2 cases had a higher incidence of fever (P = 0.008) and peak temperature (P = 0.042), with significantly elevated neutrophil percentages (> 70.0%) and reduced lymphocyte percentages (< 20.0%). Phylogenetic analysis identified genotype D accounted for 97.8% (90/92) of CV-A2 strains; two genotype C strains clustered with European isolates. Recombination analysis revealed intra- and inter-serotype events involving CV-A2, A4, and A5. CONCLUSION: CV-A2 has re-emerged as the dominant herpangina-associated enterovirus in Eastern China, demonstrating distinct clinical and hematological features. This shift in serotype prevalence underscores the need for continued surveillance to monitor its spread and interactions with other serotypes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。